These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 22711238)

  • 1. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
    Pai MP
    Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosing dilemmas in obese children.
    Mulla H; Johnson TN
    Arch Dis Child Educ Pract Ed; 2010 Aug; 95(4):112-7. PubMed ID: 20585055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of obesity on drug pharmacokinetics in humans.
    Morrish GA; Pai MP; Green B
    Expert Opin Drug Metab Toxicol; 2011 Jun; 7(6):697-706. PubMed ID: 21417960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic comparison of cockcroft-gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustment.
    Park EJ; Wu K; Mi Z; Dong T; Lawrence JP; Ko CW; Huang SM; Zhang L; Crentsil V; Zhang J; Xu NN
    Ann Pharmacother; 2012 Sep; 46(9):1174-87. PubMed ID: 22932303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the glomerular filtration rate in obese adult patients for drug dosing.
    Pai MP
    Adv Chronic Kidney Dis; 2010 Sep; 17(5):e53-62. PubMed ID: 20727504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed dosing versus body size-based dosing of monoclonal antibodies in adult clinical trials.
    Wang DD; Zhang S; Zhao H; Men AY; Parivar K
    J Clin Pharmacol; 2009 Sep; 49(9):1012-24. PubMed ID: 19620385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing in obesity: a simple solution to a big problem.
    Han PY; Duffull SB; Kirkpatrick CM; Green B
    Clin Pharmacol Ther; 2007 Nov; 82(5):505-8. PubMed ID: 17952107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving pediatric dosing through pediatric initiatives: what we have learned.
    Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS
    Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.
    Kendrick JG; Carr RR; Ensom MH
    Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent dosing and labeling since the Food and Drug Administration Amendments Act of 2007.
    Momper JD; Mulugeta Y; Green DJ; Karesh A; Krudys KM; Sachs HC; Yao LP; Burckart GJ
    JAMA Pediatr; 2013 Oct; 167(10):926-32. PubMed ID: 23921678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapolation of pharmacological and toxicological data based on metabolic weight.
    Van Miert AS
    Arch Exp Veterinarmed; 1989; 43(4):481-8. PubMed ID: 2695001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative pharmacology in morbid obesity.
    Lemmens HJ
    Curr Opin Anaesthesiol; 2010 Aug; 23(4):485-91. PubMed ID: 20531173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of busulfan in children: increased evidence for body surface area and allometric body weight dosing of busulfan in children.
    Trame MN; Bergstrand M; Karlsson MO; Boos J; Hempel G
    Clin Cancer Res; 2011 Nov; 17(21):6867-77. PubMed ID: 21918171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.
    Polso AK; Lassiter JL; Nagel JL
    J Clin Pharm Ther; 2014 Dec; 39(6):584-608. PubMed ID: 25203631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body surface area for adjustment of drug dose.
    Drug Ther Bull; 2010 Mar; 48(3):33-6. PubMed ID: 20200147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of body weight and body surface area in dosing of anticancer agents in adult patients].
    Levêque D
    Bull Cancer; 2007 Jul; 94(7):647-51. PubMed ID: 17723945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA).
    Hunter RJ; Navo MA; Thaker PH; Bodurka DC; Wolf JK; Smith JA
    Cancer Treat Rev; 2009 Feb; 35(1):69-78. PubMed ID: 18922643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flat-fixed dosing versus body surface area based dosing of anticancer drugs in adults: does it make a difference?
    Mathijssen RH; de Jong FA; Loos WJ; van der Bol JM; Verweij J; Sparreboom A
    Oncologist; 2007 Aug; 12(8):913-23. PubMed ID: 17766650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing of antibacterial agents in obese adults: does one size fit all?
    Payne KD; Hall RG
    Expert Rev Anti Infect Ther; 2014 Jul; 12(7):829-54. PubMed ID: 24809811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.